| View |
|
DR-XY41257
|
Azelastine Hydrochloride
|
Astenzyd
|
1 mg/mL (137 mcg/0.137 mL per spray)
|
Solution for Nasal Spray
|
Antihistamine
|
Cadila Healthcare Limited
|
India
|
Renewal
|
22 August 2022
|
01 October 2027
|
| View |
|
DR-XY41260
|
0.9% Sodium Chloride
|
None
|
900mg/ 100mL
|
Solution For IV Infusion
|
-
|
General Hospital Products Public Co. Ltd.
|
Thailand
|
-
|
24 July 2020
|
12 December 2026
|
| View |
|
DR-XY41262
|
Naftazone
|
Mediaven Forte
|
30 mg
|
Film-Coated Tablet
|
Vasoprotective (Capillary Stabilizing Agent)
|
Haupt Pharma Berlin GmbH
|
Germany
|
Initial (from Monitored Release Extension)
|
27 May 2022
|
01 October 2025
|
| View |
|
DR-XY41264
|
Benzydamine hydrochloride + Chlorhexidine gluconate.
|
Difflam-C
|
22.5 mg/18 mg per 15 mL
|
Solution
|
Non-Steroidal Anti-Inflammatory Drug (NSAID) /
Antiseptic
|
Ensign Laboratories Pty. Ltd.
|
Australia
|
Turned Initial
|
28 May 2024
|
28 May 2029
|
| View |
|
DR-XY41265
|
Benzydamine Hydrochloride
|
Difflam Solution
|
1.5mg/mL
|
Solution
|
-
|
Ensign Laboratories Pty. Ltd.
|
Australia
|
Automatic Renewal
|
27 July 2021
|
01 October 2025
|
| View |
|
DR-XY41267
|
Esomeprazole (As Magnesium)
|
Nexpro-20
|
20 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Torrent Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
21 July 2022
|
08 October 2027
|
| View |
|
DR-XY41273
|
Potassium Chloride 10 Meq (20 Meq/L) In 5% Dextrose And 0.33% Sodium Chloride Solution For I.V. Infusion
|
None
|
None
|
Solution For I.V. Infusion
|
Electrolyte Replenisher
|
Baxter Healthcare Philippines Inc.
|
Philippines
|
Automatic Renewal
|
03 November 2022
|
28 September 2027
|
| View |
|
DR-XY41274
|
Bupivacaine Hydrochloride
|
Bupitroy Heavy
|
5mg/mL (0.5% w/v)
|
Solution for Spinal Injection
|
Anesthetic (Amide)
|
Troikaa Pharmaceuticals Ltd.
|
India
|
Renewal
|
05 August 2022
|
28 September 2027
|
| View |
|
DR-XY41277
|
Pantoprazole (as sodium sesquihydrate)
|
Pantokem
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
ALKEM LABORATORIES LIMITED
|
India
|
Renewal
|
17 August 2022
|
28 September 2027
|
| View |
|
DR-XY41278
|
Fluphenazine Decanoate
|
Psycosin
|
25 mg/mL
|
Solution For Injection
|
Antipsychotic (Phenothiazine with piperazine structure)
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Automatic Renewal
|
30 August 2022
|
28 September 2027
|
| View |
|
DR-XY41287
|
Hypromellose
|
Equisine Moist
|
30mg
|
Ophthalmic Drops
|
Ophthalmologic Lubricant
|
Duopharma Trade Philippines Inc.
|
Philippines
|
Automatic Renewal
|
26 July 2022
|
03 October 2027
|
| View |
|
DR-XY41289
|
Tranexamic Acid
|
Suprehem
|
500 mg
|
Capsule
|
Antifibrinolytic
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
18 July 2022
|
02 October 2027
|
| View |
|
DR-XY41290
|
Paracetamol + Phenylephrine Hydrochloride + Chlorphenamine Maleate
|
Sinuplus
|
500 mg/10 mg/2 mg
|
Film-Coated Tablet
|
Analgesic-Antipyretic/ Nasal Decongestant/ Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
02 October 2027
|
| View |
DR-XY41291_PI_01.pdf
|
DR-XY41291
|
Amlodipine (As Besilate)
|
SITIvax
|
10 mg
|
Tablet
|
CALCIUM CHANNEL BLOCKER
|
Zest Pharma
|
India
|
Automatic Renewal
|
08 July 2022
|
02 October 2027
|
| View |
|
DR-XY41292
|
Doxorubicin Hydrochloride
|
Lipo-Dox
|
2mg/mL
|
Solution For Injection
|
Antineoplastic ( Anthracycline)
|
TTY Biopharm Company Limited Li Factory
|
Taiwan
|
Automatic Renewal
|
12 February 2022
|
23 October 2027
|
| View |
|
DR-XY41300
|
Polymyxin B Sulfate + Bacitracin Zinc + Neomycin Sulfate
|
None
|
710 mcg/10 mg/5 mg
|
Topical Ointment
|
Antibacterial
|
Llyod Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 September 2022
|
03 October 2027
|
| View |
|
DR-XY41307
|
Degarelix
|
Firmagon
|
120 mg
|
Freeze-dried Powder for Solution for Injection
(SC)
|
Antineoplastic (Hormone Antagonist)
|
Ferring GMBH
|
Germany
|
Initial (from Monitored Release)
|
27 June 2024
|
29 November 2027
|
| View |
|
DR-XY41308
|
Degarelix
|
Firmagon
|
80 mg
|
Freeze-dried Powder for Solution for Injection
(SC)
|
Antineoplastic (Hormone Antagonist)
|
Ferring GMBH
|
Germany
|
Initial (from Monitored Release)
|
27 June 2024
|
29 November 2027
|
| View |
|
DR-XY41311
|
Brompheniramine Maleate + Phenylephrine Hydrochloride
|
Respitapp
|
4 mg/ 12.5 mg per mL
|
Syrup
|
-
|
Accord Bio Laboratories
|
Philippines
|
-
|
28 June 2021
|
10 October 2026
|
| View |
|
DR-XY41312
|
Midazolam (as hydrochloride)
|
Unbranded
|
1mg/mL
|
Solution for Injection (I.M./I.V.)
|
Hypnotics and Sedatives (Benzodiazepines derivatives)
|
Swiss Parenterals Ltd.
|
India
|
Renewal
|
25 August 2022
|
05 November 2027
|